Newly launched Prime Medicine foresees its gene-editing technology platform has having potentially even broader utility than other technologies in development, like CRISPR/Cas9 and base editing, and h
Nearly 3,500 gene, cell and RNA therapies are in development across the world, with 77 of them in Phase III trials, and the first quarter of 2021 saw 13 start-ups raise $480m as the space continues to